Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06945263

Comparing Pain Relief Between Two Methods of Freezing Injections in Children Having Their Appendix Removed

Rectus Sheath Block and Coadministration of Intravenous Dexamethasone for Analgesia After Pediatric Laparoscopic Appendectomy - A Pilot Study

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
32 (estimated)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
4 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Laparoscopic appendectomies are the most common emergency surgeries performed in children. Despite being considered minimally invasive surgeries, they can result in substantial postoperative pain and 2 of 3 patients require postoperative opioids. Increased postoperative pain can delay recovery, increase hospital admission time, lead to chronic pain, and cause patient distress. This study aims to reduce postoperative pain in this population by comparing the recovery outcomes associated with the administration of (1) an RSB with coadministration of IV dexamethasone as an LA adjunct (RSB+dex group) prior to the incision with (2) LA infiltration alone by the surgeon (LA group).

Conditions

Interventions

TypeNameDescription
PROCEDURERectus Sheath BlockBilateral rectus sheath blocks using an in-plane ultrasound-guided technique with 0.25% bupivacaine with epinephrine 1:200 000 at 0.8 mL/kg (half of total volume per side) up to a maximum of 20 mL prior to the incision.
DRUGLocal Anesthetic at the Umbilical Port Site0.25% bupivacaine with epinephrine 1:200 000. Total dose of 0.8 mL/kg (maximum 20 mL) at the umbilical port site.
DRUGIntravenous DexamethasoneIntravenous Dexamethasone delivered concurrent to the RSB. Total dose of 150 mcg/kg up to a maximum of 8 mg.
DRUGLocal Anesthetic at the Incision SiteThe remaining volume of local anesthetic (0.2 mL/kg) can be infiltrated at each of the incision sites at the discretion of the surgeon up to a maximum of 10 mL.

Timeline

Start date
2025-05-01
Primary completion
2026-04-27
Completion
2026-04-27
First posted
2025-04-25
Last updated
2025-05-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06945263. Inclusion in this directory is not an endorsement.